Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ACTAVIS LLC

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 52
  • 0 comments

FDA approve METHYLNALTREXONE BROMIDE

Comment Full text

AMNEAL

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 49
  • 0 comments

FDA approve LEVOTHYROXINE SODIUM

Comment Full text

ACRUX DDS

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 50
  • 0 comments

FDA approve DAPSONE

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 42
  • 0 comments

FDA approve VORICONAZOLE

Comment Full text

MEITHEAL

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 44
  • 0 comments

FDA approve DESMOPRESSIN ACETATE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 50
  • 0 comments

FDA approve DOXYCYCLINE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 45
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

VISTAPHARM

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 46
  • 0 comments

FDA approve METHADONE HYDROCHLORIDE

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 41
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

DEVA HOLDING AS

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 63
  • 0 comments

FDA approve TEMOZOLOMIDE

Comment Full text
  • Previous
  • 364
  • 365
  • 366
  • 367
  • 368
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274032)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158476)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin